Search

everythinglearnresearchcommunity

for

Search:↓

Selective immunotherapies like anifrolumab and belimumab are more effective for treating systemic lupus erythematosus than traditional drugs.

SLE patients in eastern Saudi Arabia have a generally good prognosis despite multi-organ involvement.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

JAK inhibitors may soon be a safe and effective treatment for alopecia areata.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Teenage girls with Lupus often struggle with the disease's impact on their looks, which may lead them to change their medication without a doctor's advice.

New drugs for alopecia areata show promise but aren't universally effective, and hair loss often returns after stopping treatment.

A Japanese man with rare skin conditions improved with hydroxychloroquine treatment.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

Early baldness in men may indicate risks for obesity, metabolic syndrome, insulin resistance, and heart disease, similar to women with PCOS. Alopecia areata is often linked with autoimmune diseases and mental health issues. Certain hair disorders are due to genetic issues, and chemotherapy can cause hair loss through specific biological pathways. Iron deficiency's link to hair loss is still disputed.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.

Ethosomes improve drug delivery through the skin and show promise for treating male pattern baldness.

Newer retinoid drugs are effective for skin conditions but have significant side effects.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

Some chemicals absorbed through the skin can cause serious health problems.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

A young woman with lupus developed tuberculosis due to weakened immunity from her medication, showing the need for better TB screening in such patients.

Systemic corticosteroids can help treat rapidly spreading vitiligo but require more research for safer use.

Older adults diagnosed with lupus show less severe symptoms but have a lower survival rate, often due to age-related factors.

Topical finasteride and flutamide reduce gland size and enzyme activity, with flutamide being more potent, potentially treating acne, seborrhea, hirsutism, and androgenic alopecia.

New anti-acne medications are being tested to offer alternatives to current treatments.

JAK inhibitors are safe and effective for treating moderate-to-severe alopecia areata.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

Nanoparticle systems make cancer treatment less toxic.

New treatments for lupus show promise, but more research is needed, especially for children.

Cyclophosphamide has serious side effects, but long-term follow-up can help manage risks.

Two new IRAK4-inhibitors effectively reduced skin inflammation and immune response markers in healthy volunteers.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

Systemic lupus erythematosus is managed with lifestyle changes, symptomatic treatments, and careful use of medications to control symptoms and flares.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.